Literature DB >> 31144291

Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.

Nicholas Pavlidis1, Elie Rassy2,3, Julie Smith-Gagen4.   

Abstract

Cancer of unknown primary (CUP) is a clinical challenge especially when it occurs in adolescents and young adults (AYA), aged 15-39 years, due to the sparse data in this population. The available data has not described the population-based epidemiological features of CUP among AYA. Therefore, we collected patient information from the Surveillance, Epidemiology and End Results (SEER) registry, 1990-2015. Age, gender, ethnic, five pathological classification groups were assessed along with an aggregate level socioeconomic status (SES) index and population density at the county level. Incidence rates, modeled relative risks and survival of AYA patients with CUP were assessed. Among 2,480 AYA patients, 907 met the definition of standard pathology classifications. The majority of AYA patients with CUP had a neuroendocrine, squamous cell and poorly differentiated carcinomas with 0.4 cases per 1,000,000 population. AYA living in areas with the highest SES level had the highest risks of CUP; adjusted relative risks (ARR) of 1.17 (95% CI 1.0-1.4) and 1.99 (95% CI 1.5-2.6), respectively. AYA living in nonmetropolitan areas had a lower risk of CUP (ARR = 0.16; 95% CI 0.1-0.2). The incidence of differentiated neoplasms has been decreasing slower than undifferentiated neoplasms since the early 1990s. The median overall survival (OS) was 11 months (95% CI 9-13 months) with squamous CUP having the longest median OS 16 years (95% CI 3-24 years). In conclusion, this analysis answers several gaps in the knowledge of CUP among AYA and provides a platform to better understand this disease and its management within this group.
© 2019 UICC.

Entities:  

Keywords:  CUP; adolescent and young adult; cancer of unknown primary; epidemiology; survival; time trends

Mesh:

Year:  2019        PMID: 31144291     DOI: 10.1002/ijc.32482

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

2.  Global, Regional, and National Burden of Cancer in Children Younger Than 5 Years, 1990-2019: Analysis of the Global Burden of Disease Study 2019.

Authors:  Hui-Ming Ren; Min-Qi Liao; Si-Xian Tan; Chen Cheng; Sui Zhu; Lu Zheng; Jun-Rong Ma; Ying-Jun Mu; Wan-Lin Li; Shi-Wen Zhang; Rui-Qing OuYang; Shu-Na Li; Yun-Feng Cui; Xing-Yao Ke; Ze-Yan Luo; Peng Xiong; Jun Liu; Li-Ping Li; Xiao-Feng Liang; Fang-Fang Zeng; Xue-Fen Su; Li-Yuan Han
Journal:  Front Public Health       Date:  2022-06-21

3.  Case Report: Long-Term Survival of a Pediatric Patient With an Intra-Abdominal Undifferentiated Carcinoma of Unknown Primary.

Authors:  Anja Stirnweiss; Hetal Dholaria; Joyce Oommen; Kathy Hardy; Gareth Jevon; Alex H Beesley; Rishi S Kotecha
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

4.  Family history of cancer in first degree relatives and risk of cancer of unknown primary.

Authors:  Alexander L R Grewcock; Karlijn E P E Hermans; Matty P Weijenberg; Piet A van den Brandt; Caroline Loef; Rob L H Jansen; Leo J Schouten
Journal:  Eur J Cancer Care (Engl)       Date:  2021-07-05       Impact factor: 2.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.